Rafat Milad Mohareb

Dr. Rafat Milad Mohareb is a distinguished academic author and researcher in organic and medicinal chemistry, with a prolific record of publications in 2023 alone. His work focuses on synthesizing and evaluating heterocyclic compounds for anticancer and antiviral applications, particularly targeting SARS-CoV-2 and cancer therapeutics.

• Recent affiliations include Cairo University (Faculty of Science), Alexandria University (Faculty of Education), MSA University, American University in Cairo (School of Sciences and Engineering), and University of California, Berkeley (Faculty of Science).
• His research spans interdisciplinary fields including molecular docking, c-Met inhibition, and bioactive compound synthesis.

Dr. Mohareb’s publications appear in journals such as Combinatorial Chemistry and High Throughput Screening, Anti-Cancer Agents in Medicinal Chemistry, and Organic Communications. He has secured funding from global institutions like the National Research Foundation, European Commission, and King Saud University. With 194 publications, 2,574 citations, and a high H-index, his work demonstrates significant academic influence. Collaborative efforts with co-authors (98.9% co-authored) further underscore his impact on the scientific community.